This is a PDF-only article. The first page of the PDF of this article appears above.
In this issue
Jump to section
Related Articles
Cited By...
- Effect of Diet on Physiologic Bowel 18F-FDG Uptake
- Appropriate Use Criteria for 18F-FDG PET/CT in Restaging and Treatment Response Assessment of Malignant Disease
- Pretargeted Immuno-Positron Emission Tomography Imaging of Carcinoembryonic Antigen-Expressing Tumors with a Bispecific Antibody and a 68Ga- and 18F-Labeled Hapten Peptide in Mice with Human Tumor Xenografts
- Evidence-Based Approach to the Introduction of Positron Emission Tomography in Ontario, Canada
- 18F-FDG Uptake in Lung, Breast, and Colon Cancers: Molecular Biology Correlates and Disease Characterization
- Improved Selection of Patients for Hepatic Surgery of Colorectal Liver Metastases with 18F-FDG PET: A Randomized Study
- PET Changes Management and Improves Prognostic Stratification in Patients with Recurrent Colorectal Cancer: Results of a Multicenter Prospective Study
- Detection of Hepatocellular Carcinoma Using 11C-Choline PET: Comparison with 18F-FDG PET
- Recommendations on the Use of 18F-FDG PET in Oncology
- Limitations of CT During PET/CT
- Early Detection of Cancer Recurrence: 18F-FDG PET/CT Can Make a Difference in Diagnosis and Patient Care
- Positron emission tomography scanning is not superior to whole body multidetector helical computed tomography in the preoperative staging of colorectal cancer
- Combined PET/CT colonography: is this the way forward?
- The contribution of PET/CT to improved patient management
- Whole body positron emission tomography/computed tomography (PET/CT) tumour staging with integrated PET/CT colonography: technical feasibility and first experiences in patients with colorectal cancer
- Progress and Promise of FDG-PET Imaging for Cancer Patient Management and Oncologic Drug Development
- Clinical Decisions Associated With Positron Emission Tomography in a Prospective Cohort of Patients With Suspected or Known Cancer at One United States Center
- [18F]Fluoro-2-deoxy-D-glucose Positron Emission Tomography Detects Gastric Carcinoma in an Early Stage in an Asymptomatic E-Cadherin Mutation Carrier
- PET/CT in Oncology: Integration into Clinical Management of Lymphoma, Melanoma, and Gastrointestinal Malignancies
- Meta-Analysis of the Performance of 18F-FDG PET in Primary Tumor Detection in Unknown Primary Tumors
- 18F-Fluoro-2-deoxyglucose positron emission tomography in the evaluation of gastrointestinal malignancies
- The Role of Positron Emission Tomography in Colorectal Carcinoma
- The Clinical Impact of 18F-FDG PET in Patients with Suspected or Confirmed Recurrence of Colorectal Cancer: A Prospective Study